Serum microRNAs as biomarkers for recurrence in melanoma. - Wikidata - awgldk - TriplyDB

Serum microRNAs as biomarkers for recurrence in melanoma.

Serum microRNAs as biomarkers for recurrence in melanoma.

http://www.wikidata.org/entity/Q36341127

about

Noninvasive micromarkers The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos.miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.Revisiting determinants of prognosis in cutaneous melanoma.Detection of Exosomal miRNAs in the Plasma of Melanoma Patients.Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.Protein and non-protein biomarkers in melanoma: a critical update.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Melanoma epigenetics: novel mechanisms, markers, and medicines.Recent progress in studies of miRNA and skin diseases.Prognostic and predictive biomarkers in melanoma: an update.Circulating epigenetic biomarkers in melanoma.Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients Concordance measure and discriminatory accuracy in transformation cure models.Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.MicroRNAs role as potential biomarkers and key regulators in melanoma.Metastatic pathways in patients with cutaneous melanoma.MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy.New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.Down-regulated miR-23a Contributes to the Metastasis of Cutaneous Melanoma by Promoting Autophagy.Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients.Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.Epigenetic regulation of melanoma tumor suppressor miRNA-124a.Development and validation of a plasma-based melanoma biomarker suitable for clinical use.Liquid biomarkers in melanoma: detection and discovery.Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.

P2860

Q34111606-F847E0D7-D8E1-4FD2-8444-85B01BCABAED Q34459058-EF35DEFD-10BD-4EE5-B4E7-5F58E8A68674 Q34735084-FBAFD94F-80D4-4B13-A23A-601AA76A618D Q35569508-378456CF-DCDB-4AA6-B457-0D734A15E17A Q35661627-2DDCF9AB-76F5-4329-8061-241439B7FDE5 Q35740150-042A1E3B-296F-4502-952D-7C9F29E31629 Q35828512-193DCEBE-4559-4EB9-B5C3-F7F88CD0508E Q35947544-382865DB-42B8-4EC6-8E3E-6D60C0B0E387 Q36191656-E71A09C4-F104-437C-944C-74E63F37D56B Q36212884-8FA107C3-2A72-4A0F-80FD-DE6B9503DBAF Q36244744-52B42E73-ABF7-43F8-8401-6EBFD1E146EE Q36338825-23CFBDF6-1865-433B-8962-0D244ADB3EBA Q36409368-C4DD2075-7913-43A8-A9D2-D69090C9301B Q37069223-9C6B8277-25CF-4062-9708-E72C2A27AFF0 Q37305975-8CEB254A-4AD6-4A8F-8047-5CE8A21BBC61 Q37693673-6FF03B8C-35EF-4C49-A1D0-99CD7A755A24 Q38050990-CA3CE342-FF4B-491B-9062-5AAFDD1C2BDA Q38138933-AFE30B86-C411-482F-B745-6A4138C96F61 Q38185688-78362EB8-BF29-4A8D-A3C1-7C660932B85B Q38224624-CDA33266-F1D4-4F4C-A5C7-1907EBCBDF63 Q38444825-C763E8AD-3DED-4897-9972-27CBE9175864 Q38653619-B561000D-C3BA-4BA8-A9AA-2C210E44F421 Q38668171-C566882D-5FDA-462B-899F-C9099731AD92 Q38700529-8CF829C0-1124-4534-9EE4-44F2DA031817 Q38798132-BDEF1526-3F7B-4099-B5B9-42BC8937FBAE Q38807433-7920B736-ECED-4834-9EB1-ED1868F53410 Q38937088-15DBE9D2-ACF6-4D9A-8A44-A972071692F0 Q39024316-7BCE5C8B-9C6A-4564-8240-0C8B40226D21 Q39215885-44AD272B-DD0B-4E65-8B0F-315C42C46820 Q40406145-8E0555BA-0A0A-43B3-BC80-90CE32B51B17 Q40980381-7E5F406E-D446-4BC7-8BE0-1CD12C95ADD7 Q41763210-657841C0-5A25-4427-93BB-7C3AB4F89D31 Q43451695-D26EEE12-B06B-4FCD-A0BE-9928C441C7DA Q44888480-B400D065-B21B-4B7F-9128-7349FFBB7BAB Q47557515-1C467DDB-3D92-4B50-B3C4-57C5DCEFD1CB Q47726847-7119F323-4DA4-495D-8597-63952C453112 Q48108646-8F5C8E24-3844-4010-AE30-257648BF1D94 Q49647487-652B7A38-4D22-46E5-8F78-A1AFCF19EE36 Q55069393-AB84531C-5B00-44D8-8080-6FF9AB45A1E2 Q55428812-52816509-7B94-471A-A44F-39B0C6C59101

P2860

Serum microRNAs as biomarkers for recurrence in melanoma.

http://www.wikidata.org/entity/Q36341127

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Serum microRNAs as biomarkers for recurrence in melanoma.

@ast

Serum microRNAs as biomarkers for recurrence in melanoma.

@en

type

label

Serum microRNAs as biomarkers for recurrence in melanoma.

@ast

Serum microRNAs as biomarkers for recurrence in melanoma.

@en

prefLabel

Serum microRNAs as biomarkers for recurrence in melanoma.

@ast

Serum microRNAs as biomarkers for recurrence in melanoma.

@en

P1433

Q36341127-FC221F0D-FA38-4EA6-B5D3-1AC346BF768C

P1476

Q36341127-DF108401-BD76-4FB2-BCD3-E0CD503A59E1

P2093

Q36341127-2FEE3C96-1F90-4F4F-8006-1D9E88830C9D

Q36341127-36884DC4-DDC8-4189-9DFE-084FBBB8092A

Q36341127-4EB1999B-CFFE-446D-B3B2-FDF289D19101

Q36341127-661D041C-983B-407F-9B27-FB689E522A71

Q36341127-6AA3D3DB-60F5-42D0-8495-91A94977ADA5

Q36341127-792B5196-1ED7-4CB2-BEC9-CB518F61561C

Q36341127-C08241C2-E76F-46AE-9C63-358472DF3279

Q36341127-C915BE62-BC2A-4634-8A3C-949BB7B3FD30

Q36341127-EC874152-18A0-40E3-AB07-F066D0C34BA0

Q36341127-F843278C-F529-46A3-85B3-9F8C5A4CFCCB

P2860

Q36341127-08ACE2A2-389B-4A22-A2FB-0BEE72C7C90F

Q36341127-0D410CDF-4948-4BA8-874C-1C7ADDA6B9DB

Q36341127-0DE72C65-5720-4B62-A109-58E4B4E0B1DA

Q36341127-0EC9E816-E3F0-434E-BCF1-E62620910102

Q36341127-153C5D9C-B191-48D7-9C82-30BBA3A48468

Q36341127-1A9993ED-828E-427B-99AA-316C06C2C7C2

Q36341127-1EC947F0-F625-487C-B0CB-FDBDF99D6E8E

Q36341127-246D30C0-4346-49B3-A931-06FD73358259

Q36341127-274F8CA8-6419-4CA0-9B2C-F9973C74DEDD

Q36341127-3225F5A7-3EB2-45A2-AE93-38302A026403

P2888

Q36341127-A9383DAA-4835-4C02-B9F7-4065BC86B5EF

P304

Q36341127-2B27F371-E2A7-49D5-8369-0C96F16FE6FE

P31

Q36341127-F39DA442-5E4A-4AF2-8E35-248E884F24A1

P356

Q36341127-2A7941D9-1919-47A6-9778-7EBCF6946B2C

P478

Q36341127-8C9329E6-5CB1-4F78-B068-239163AA9386

P50

Q36341127-11D9E54A-E30A-415F-B4D5-9F97ABB46BDB

Q36341127-5DCB58F3-3D23-481E-BDA5-E12F13DD40B6

Q36341127-640E4FDA-1527-4F06-9B78-C180E0D4B648

P577

Q36341127-DFC3E13C-F0CF-4068-B8FA-38707F72E4EE

P5875

Q36341127-2CC407E9-7465-446C-A213-C02C96AA6795

P6179

Q36341127-BC0F1CD6-5690-4986-A6F4-406E32645144

P698

Q36341127-35BF0B1C-B573-49B0-AC73-9CBA2C739750

P921

Q36341127-0CAA1F5D-049F-4440-A1C4-E8E0C44E83D0

Q36341127-90AD474A-ADDF-44D4-A1D8-68FDBE00EE0F

P932

Q36341127-D3DE71FB-D0D7-4AAC-B045-F460F0639011

P356

1479-5876-10-155

P1433

Journal of Translational Medicine

P1476

Serum microRNAs as biomarkers for recurrence in melanoma

@en

P2093

Adam Baker

http://www.w3.org/2001/XMLSchema#string

Anna C Pavlick

http://www.w3.org/2001/XMLSchema#string

Eleazar Vega-Saenz de Miera

http://www.w3.org/2001/XMLSchema#string

Iman Osman

http://www.w3.org/2001/XMLSchema#string

Jacob Ulrik Fog

http://www.w3.org/2001/XMLSchema#string

Maria Wrang Teilum

http://www.w3.org/2001/XMLSchema#string

Michelle W Ma

http://www.w3.org/2001/XMLSchema#string

Richard L Shapiro

http://www.w3.org/2001/XMLSchema#string

Shulian Shang

http://www.w3.org/2001/XMLSchema#string

Yongzhao Shao

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA expression profiles classify human cancers

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

Final version of 2009 AJCC melanoma staging and classification

MicroRNA-221 and -222 pathway controls melanoma progression.

High-throughput miRNA profiling of human melanoma blood samples.

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.

P2888

1479-5876-10-155

P304

155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-10-155

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Erica B Friedman

P577

2012-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230614666

http://www.w3.org/2001/XMLSchema#string

P6179

1010765782

http://www.w3.org/2001/XMLSchema#string

P698

22857597

http://www.w3.org/2001/XMLSchema#string

P921

P932

3479021

http://www.w3.org/2001/XMLSchema#string